Clinical Trial: The Study of Mesenchymal Stem Cells Treat Autoimmune Pulmonary Alveolar Proteinosis in Vitro
Study Status: Active, not recruiting
Recruit Status: Active, not recruiting
Condition: Pulmonary Alveolar Proteinosis(PAP)
Study Type: Observational
Official Title: The Study of Mesenchymal Stem Cells Treat Autoimmune Pulmonary Alveolar in Vitro
Brief Summary:
Autoimmune pulmonary alveolar proteinosis (aPAP) is a respiratory disease characterized by massive deposition of pulmonary surfactant in the alveoli, involving a variety of immune cells and factor disorders. However, there are certain limits in treatment at present. MSCs can improve the microenvironment in the alveoli by regulating immunity, thereby achieving a good therapeutic effect. The purpose of this study is to use the lavage fluid obtained after whole lung lavage with aPAP to isolate alveolar macrophages,…
Read more